Page last updated: 2024-09-03

benzyloxycarbonylarginyl-arginine 4-methylcoumarin-7-ylamide and Malaria, Falciparum

benzyloxycarbonylarginyl-arginine 4-methylcoumarin-7-ylamide has been researched along with Malaria, Falciparum in 1 studies

*Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allanki, AD; Deshmukh, MV; Kolla, VK; Navale, R; Prasad, R; Sayyad, Z; Shah, AY; Sijwali, PS; Singhal, N; Sudhakar, R; Tanneru, N; Venkatesan, V1

Other Studies

1 other study(ies) available for benzyloxycarbonylarginyl-arginine 4-methylcoumarin-7-ylamide and Malaria, Falciparum

ArticleYear
Independent amino acid residues in the S2 pocket of falcipain-3 determine its specificity for P2 residues in substrates.
    Molecular and biochemical parasitology, 2015, Volume: 202, Issue:2

    Topics: Amino Acid Sequence; Catalytic Domain; Cathepsin L; Coumarins; Cysteine Endopeptidases; Dipeptides; Hemoglobins; Humans; Hydrogen-Ion Concentration; Hydrolysis; Leucine; Malaria, Falciparum; Molecular Sequence Data; Mutagenesis, Site-Directed; Peptides; Plasmodium falciparum; Protozoan Proteins; Substrate Specificity

2015